Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: Comparisons of phospholipid specificity, avidity and reactivity with beta 2-GPI
C. Petrovas et al., Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: Comparisons of phospholipid specificity, avidity and reactivity with beta 2-GPI, J AUTOIMMUN, 13(3), 1999, pp. 347-355
Increased prevalence of anti-phospholipid antibodies (aPL) and increased le
vels of lipid peroxidation have been described in patients with HIV infecti
on. To assess the binding specificity and avidity or aPL antibodies in HIV
infection, sera from 44 HIV-1 infected patients were evaluated for antibodi
es td cardiolipin (aCL), phosphatidyl serine (aPS), phosphatidyl inositol (
aPI) and phosphatidyl choline (aPC) using enzyme linked immunosorbent assay
(ELISA) methods, Sera from 30 patients with systemic-lupus erythematosus (
SLE), but without features of anti-phospholipid syndrome (APS) (SLE/non APS
); six with SLE and secondary APS, (SLE/APS) and 11 with primary APS (PAPS)
were also evaluated as controls. The resistance of the aPL antibody bindin
g to dissociating agents was evaluated by treating the ELISA wells, after s
erum incubation with 2M urea-or 0.6 M NaCl for 10 min. An anti-beta 2-glyco
protein-I (beta 2-GPI) ELISA was used to assess serum reactivity against be
ta 2-GPI, a plasma protein considered as the true antigen of aCL antibodies
occurring in APS and SLE patients, The prevalence of aCL, aPS, aPI and aPC
antibodies in HIV-1 infection was 36%, 56%, 34% and 43% respectively, whic
h was:comparable to that found in SLE/APS and PAPS,patients and significant
ly higher than that observed in SLE/non-APS patients. Anti-beta 2-GPI antib
odies occurred in 5% of HIV-1 infected vs. 17% in SLE/non-APS (P=0.11), 50%
in SLE/APS (P = 0.009) and 70% in PAPS patients (P = 0.0014). A significan
t decrease of aPL binding after urea and NaCl treatment was observed in the
sera of HIV-1-infected, compared to that of APS patients, indicating that
aPL antibodies from HIV-1 infected individuals have low resistance to disso
ciating agents. Ln conclusion, aPL antibodies (1) occur in HIV-1 infection;
(2)tend-to recognize various phospholipids but not beta 2-GPI; and (3) are
of low resistance to dissociating agents-a finding probably reflecting low
antibody avidity. Finally, these, like the autoimmune-type aCL antibodies,
tend to recognize the oxidized CL-a finding probably indicating autoantibo
dy generation as a result of neoepitope formation by oxidized PLs; (C) 1999
Academic Press.